Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo

Abstract MicroRNAs, which can contribute to numerous cellular functions through post-transcriptional silencing, have become well-documented candidates for cancer treatment applications, particularly in chemo-resistant cancers. Herein, several formulations were examined to optimize the essential para...

Full description

Bibliographic Details
Main Authors: Najmeh Alsadat Abtahi, Saba Salehi, Seyed Morteza Naghib, Fatemeh Haghiralsadat, Mohammadmahdi Akbari Edgahi, Sadegh Ghorbanzadeh, Wei Zhang
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Cancer Nanotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12645-023-00175-w
_version_ 1797865548715917312
author Najmeh Alsadat Abtahi
Saba Salehi
Seyed Morteza Naghib
Fatemeh Haghiralsadat
Mohammadmahdi Akbari Edgahi
Sadegh Ghorbanzadeh
Wei Zhang
author_facet Najmeh Alsadat Abtahi
Saba Salehi
Seyed Morteza Naghib
Fatemeh Haghiralsadat
Mohammadmahdi Akbari Edgahi
Sadegh Ghorbanzadeh
Wei Zhang
author_sort Najmeh Alsadat Abtahi
collection DOAJ
description Abstract MicroRNAs, which can contribute to numerous cellular functions through post-transcriptional silencing, have become well-documented candidates for cancer treatment applications, particularly in chemo-resistant cancers. Herein, several formulations were examined to optimize the essential parameters, and the niosomal formulation consisting of cholesterol:tween-80:DOTAP:PEG with 9:69:15:7 ratio had the best physicochemical parameters including spherical shape, high entrapment efficiency, small diameter (81 ± 0.65 nm), and appropriate positive charge (23 ± 0.64 mV). Here, we aimed to design a system with increased delivery efficiency which was tested by the encapsulation of miR-34a within niosome NPs and assessed the nano-niosomal delivery of miR-34a as a tumor suppressor in MCF-7 human adenocarcinoma cells. The results showed that our novel niosome systems with non-ionic surfactants can successfully eliminate cancer cells by increasing the expression of p53 and reducing the expression of NF-κB. In comparison with the free dispersion of miR-34a, the lysis of a nano-sized delivery system demonstrated a better cytotoxicity effect against cancer cells. Similar results were obtained by performing in vivo test on the 4T1 xenografted Balb/C mouse tumor model and the miR-34a-loaded niosomes displayed a better reduction in tumor size by improving approximately + 13% in tumor inhabitation rate while maintaining the bodyweight close to the first day. Therefore, it is concluded that miR-34a delivery via niosomes has high potential as a tumor suppressor and a reliable procedure for breast cancer treatment. Graphical Abstract
first_indexed 2024-04-09T23:10:57Z
format Article
id doaj.art-970357e3ce724badafaa2652a1bb1063
institution Directory Open Access Journal
issn 1868-6958
1868-6966
language English
last_indexed 2024-04-09T23:10:57Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Cancer Nanotechnology
spelling doaj.art-970357e3ce724badafaa2652a1bb10632023-03-22T10:25:15ZengBMCCancer Nanotechnology1868-69581868-69662023-03-0114111810.1186/s12645-023-00175-wMulti-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivoNajmeh Alsadat Abtahi0Saba Salehi1Seyed Morteza Naghib2Fatemeh Haghiralsadat3Mohammadmahdi Akbari Edgahi4Sadegh Ghorbanzadeh5Wei Zhang6Nanotechnology Department, School of Advanced Technologies, Iran University of Science and TechnologyNanotechnology Department, School of Advanced Technologies, Iran University of Science and TechnologyNanotechnology Department, School of Advanced Technologies, Iran University of Science and TechnologyMedical Nanotechnology and Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical SciencesNanotechnology Department, School of Advanced Technologies, Iran University of Science and TechnologyState Key Laboratory of Structure Analysis for Industrial Equipment, Department of Engineering Mechanics, Dalian University of TechnologyState Key Laboratory of Structure Analysis for Industrial Equipment, Department of Engineering Mechanics, Dalian University of TechnologyAbstract MicroRNAs, which can contribute to numerous cellular functions through post-transcriptional silencing, have become well-documented candidates for cancer treatment applications, particularly in chemo-resistant cancers. Herein, several formulations were examined to optimize the essential parameters, and the niosomal formulation consisting of cholesterol:tween-80:DOTAP:PEG with 9:69:15:7 ratio had the best physicochemical parameters including spherical shape, high entrapment efficiency, small diameter (81 ± 0.65 nm), and appropriate positive charge (23 ± 0.64 mV). Here, we aimed to design a system with increased delivery efficiency which was tested by the encapsulation of miR-34a within niosome NPs and assessed the nano-niosomal delivery of miR-34a as a tumor suppressor in MCF-7 human adenocarcinoma cells. The results showed that our novel niosome systems with non-ionic surfactants can successfully eliminate cancer cells by increasing the expression of p53 and reducing the expression of NF-κB. In comparison with the free dispersion of miR-34a, the lysis of a nano-sized delivery system demonstrated a better cytotoxicity effect against cancer cells. Similar results were obtained by performing in vivo test on the 4T1 xenografted Balb/C mouse tumor model and the miR-34a-loaded niosomes displayed a better reduction in tumor size by improving approximately + 13% in tumor inhabitation rate while maintaining the bodyweight close to the first day. Therefore, it is concluded that miR-34a delivery via niosomes has high potential as a tumor suppressor and a reliable procedure for breast cancer treatment. Graphical Abstracthttps://doi.org/10.1186/s12645-023-00175-wmiR-34aNiosomeBreast cancerTumor suppressorGene deliveryMCF-7
spellingShingle Najmeh Alsadat Abtahi
Saba Salehi
Seyed Morteza Naghib
Fatemeh Haghiralsadat
Mohammadmahdi Akbari Edgahi
Sadegh Ghorbanzadeh
Wei Zhang
Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
Cancer Nanotechnology
miR-34a
Niosome
Breast cancer
Tumor suppressor
Gene delivery
MCF-7
title Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
title_full Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
title_fullStr Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
title_full_unstemmed Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
title_short Multi-sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
title_sort multi sensitive functionalized niosomal nanocarriers for controllable gene delivery in vitro and in vivo
topic miR-34a
Niosome
Breast cancer
Tumor suppressor
Gene delivery
MCF-7
url https://doi.org/10.1186/s12645-023-00175-w
work_keys_str_mv AT najmehalsadatabtahi multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo
AT sabasalehi multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo
AT seyedmortezanaghib multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo
AT fatemehhaghiralsadat multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo
AT mohammadmahdiakbariedgahi multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo
AT sadeghghorbanzadeh multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo
AT weizhang multisensitivefunctionalizedniosomalnanocarriersforcontrollablegenedeliveryinvitroandinvivo